PEDRO
PÉREZ SEGURA
Profesor asociado de Ciencias de la Salud
MARÍA NIEVES
CABRERA MARTÍN
Profesora asociada de Ciencias de la Salud
Publicaciones en las que colabora con MARÍA NIEVES CABRERA MARTÍN (12)
2024
-
Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With Vismodegib
Oncologist, Vol. 29, Núm. 5, pp. 377-383
-
Response to Yilmaz et al.
Anti-Cancer Drugs
2023
-
Durable complete remission with local therapies after neoadjuvant and adjuvant nivolumab in recurrent/metastatic head and neck cancer
Anti-Cancer Drugs, Vol. 34, Núm. 5, pp. 695-698
-
Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer
Oncology Letters, Vol. 25, Núm. 1
2022
2021
-
Major and durable response to second-line pembrolizumab-carboplatin-paclitaxel in an oral cavity cancer patient
Anti-Cancer Drugs, Vol. 32, Núm. 5, pp. 580-584
-
Major pathological response and durable locoregional control after neoadjuvant pembrolizumab-carboplatin-paclitaxel in head and neck cancer
Oral Oncology
-
Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer
Oncologist, Vol. 26, Núm. 6, pp. e1018-e1035
-
Tumor cerebral de alto grado versus accidente cerebrovascular. Utilidad del corregistro de PET y RM
Anales de la Real Academia Nacional de Medicina, Núm. 138, pp. 176-179
2020
2019
-
Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer
Head and Neck, Vol. 41, Núm. 6, pp. E86-E92
-
Response to immunotherapy rechallenge after interval chemotherapy in a patient with head and neck cancer
Anti-Cancer Drugs, Vol. 30, Núm. 2, pp. 149-152